Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debasish Sundi

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Urologic Oncology|January 13, 2021
Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival timesZachary R McCaw, Anobel Y Odisho, Hemant Chaparala, et al.
Cancers|January 8, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary MalignanciesAdam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Cancer|January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissectionRobert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Frontiers in Oncology|August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinomaChristopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
Cancer Biology & Therapy|September 4, 2010
Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cellsAdam R Metwalli, Sanaz Khanbolooki, Goodwin Jinesh, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
Clinical Genitourinary Cancer|May 25, 2015
Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins ExperienceMark W Ball, Debasish Sundi, Adam C Reese, et al.
Cancers|February 24, 2024
Roles of Androgen Receptor Signaling in Urothelial CarcinomaDebasish Sundi, Katharine A Collier, Yuanquan Yang, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Urologic Oncology|January 13, 2021
Neoadjuvant chemotherapy in bladder cancer: Clinical benefit observed in prospective trials computed with restricted mean survival timesZachary R McCaw, Anobel Y Odisho, Hemant Chaparala, et al.
Cancers|January 8, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary MalignanciesAdam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
European Urology|April 19, 2025
A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder CancerSaum Ghodoussipour, Trinity Bivalacqua, Richard T Bryan, et al.
Cancer|January 22, 2009
Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissectionRobert S Svatek, Philippe E Spiess, Debasish Sundi, et al.
Frontiers in Oncology|August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinomaChristopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
Cancer Biology & Therapy|September 4, 2010
Smac mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cellsAdam R Metwalli, Sanaz Khanbolooki, Goodwin Jinesh, et al.
Oncotarget|August 6, 2016
Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisBeat Roth, Isuru Jayaratna, Debasish Sundi, et al.
Clinical Genitourinary Cancer|May 25, 2015
Multimodal Therapy in the Treatment of Prostate Sarcoma: The Johns Hopkins ExperienceMark W Ball, Debasish Sundi, Adam C Reese, et al.
Cancers|February 24, 2024
Roles of Androgen Receptor Signaling in Urothelial CarcinomaDebasish Sundi, Katharine A Collier, Yuanquan Yang, et al.
Pageof 8